Intravenous Transportation Systems Market Growth Pursuant to Growing Portable IV Poles Demand
Rising need to decongest healthcare spaces to enhance patient comfort enhancing popularity across key geographies
Fact.MR, Rockville MD: Award winning market research company Fact.MR’s ongoing intravenous transportation system market report forecasts a positive growth outlook for 2021, building upon the gain accrued in 2020 amid high adoption for providing enhanced care to COVID-19 patients. Moreover, increasing demand for enhancing workflows in hospitals and clinics by reducing equipment clutter is a principal driver spearheading the market’s growth since several years.
Globally, healthcare infrastructure spending is experiencing a prolific increase. This is underpinned by a growing patient pool and subsequent increase in the establishment of hospitals, clinics and other healthcare settings. As per the World Health Organization’s report, global healthcare expenditure amounted to US$ 7.8 trillion in 2017, representing 10% of the world’s GDP. In several low income countries, development assistance funds 20-40% of primary healthcare spending.
A significant chunk of this spending is directed towards streamlining hospital and clinical workflows, which involves major emphasis on decluttering hospital space. This has been majorly achieved by investing in portable diagnostic and surgical equipment, including intravenous transportation systems. Demand for portable IV poles is expected to remain especially robust, with manufacturers such as Carex emerging at the forefront of this industry.
“Multiplying expenditure to improve healthcare delivery to patients is prompting healthcare settings to streamline their existing workflows, leading to increased investments in intravenous transportation systems,” says the Fact.MR analyst.
Request a report sample to gain comprehensive insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=3992
Key Takeaways from Fact.MR’s Intravenous Transportation Systems Study
- By product, portable IV poles are expected to yield high revenue amid improved ergonomics
- Emphasis on workflow streamlining to cement hospital-grade IV transportation system dominance
- US to emerge at the forefront, attributed to rising investments in improving hospital workflow
- High hospitalization rates to treat ischemic heart disease to bolster intravenous transport system sales in the UK
- Germany and France to registered increased sales amid high demand for reducing drug administration error margins
- India to emerge as a heavyweight in the Asian landscape amid rising need for improving patient care
Intravenous Transportation System Market- Prominent Drivers
- Burgeoning healthcare expenditure to improve hospital and clinical workflow to elevate growth prospects
- Increasing prevalence of chronic and infectious ailments to enhance demand for fast acting drugs, widening IV transportation systems usage
- Manufacturers are emphasizing on producing specially equipped IV poles for children’s wards, ICUs and surgical areas
Intravenous Transportation System Market- Key Restraints
- Surging healthcare costs may lead to additional expenditure, particularly in developing regions, limiting uptake
- Instruments manufactured from metals are highly prone to corrosion, prompting constant replacements, restraining growth
Discover more about the intravenous transportation system market with figures, data tables and the table of contents. You will also find detailed market segmentation on https://www.factmr.com/report/3992/intravenous-transportation-system-market
Competitive Landscape
Key players profiled in Fact.MR’s intravenous transportation system market study include Nexxspan Healthcare Inc., Skytron LLC, Liebherr, Mediplus, Becton Dickinson and Co., 3M Company, Certara and Astellas Pharma Inc. to name a few. Aforementioned players bank on new product launches, acquisitions and collaborations with various partners among other expansion strategies.
Nexxspan Healthcare Inc. is a prominent manufacturer in this regard. It markets the TADTM IV Transfer System, comprising of a transfer device with a pole, a bed adapter and a headwall or boom adapter. The system eliminates the need for manual lifting of equipment, streamlines workflow and reduces transfer time to as less as 15 seconds. Moreover, the IV pole docks and rotates with the bed’s footprint.
Likewise, Skytron LLC manufactures the Streamline IV Transport System, comprising of a suspension arm that aligns with the suspension stand and locks in place. Also, the release pedal automatically retracts the suspension stand legs. The system enables patient to spend less waiting time and higher recovery time in a quieter setting. Moreover, nurses can spend more time caregiving and less in transporting.
More Insights on the Intravenous Transportation System Market
In its ongoing study, Fact.MR offers unbiased analysis of the global intravenous transportation system market. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of product type (multi-purpose surgical drape clamp, IV lock box, ziplift IV transfer system, portable IV pole, detachable IV transport system and V & Irrigation Fluid Tower) and end users (hospitals, specialty clinics and ambulatory surgical centers) across six major regions (North America, Latin America, Europe, APEJ, Japan and Middle East & Africa).
Request for No-Obligation Table of Content
https://www.factmr.com/connectus/sample?flag=T&rep_id=3992
Explore Fact.MR’s Coverage on the Healthcare Domain
Softgel Capsules Market: A recent study by Fact.MR on the softgel capsules market offers a 10-year forecast from 2021 to 2031. The study analyzes crucial trends that are currently determining market growth. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders and emerging players associated with softgel capsules.
Patient Lateral Transfer Market: An extensive study undertaken by Fact.MR on the patient lateral transfer market brings to fore detailed insights expected to shape future growth of the landscape. Market statistics have been provided on the basis of key segments’ respective shares across prominent geographies. Furthermore, a detailed competitive landscape has been provided, offering a realistic growth picture for forthcoming years.
Recombinant Protein Market: Fact.MR’s recombinant protein market report analyzes expected growth trends for the upcoming decade, and provides readers an unbiased and accurate analysis. Medical device manufacturers, research institutes, and raw material suppliers in the global recombinant protein market can benefit from the analysis offered in this report.
About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Follow Us: LinkedIn | Twitter
Market Intelligence Services: Marketngage.com
Source: Fact.MR